A trial of a therapeutic vaccine against HIV induces cellular immunity and, although it provides hope, it highlights the hurdles for the development of such strategies.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$32.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Koup, R. A. et al. J. Virol. 68, 4650–4655 (1994).
Cartwright, E. K. et al. Immunity 45, 656–668 (2016).
Betts, M. R. et al. Blood 107, 4781–4789 (2006).
O’Brien, S. J., Gao, X. & Carrington, M. Trends Mol. Med. 7, 379–381 (2001).
Colby, D.J. et al. Nat. Med. https://doi.org/10.1038/s41591-020-0774-y (2020).
El-Sadr, W. M. et al. N. Engl. J. Med. 355, 2283–2296 (2006).
Li, J. Z. et al. AIDS 30, 343–353 (2016).
Robb, M. L. & Ananworanich, J. Curr. Opin. HIV AIDS 11, 555–560 (2016).
Deng, K. et al. Nature 517, 381–385 (2015).
Sáez-Cirión, A. et al. PLoS Pathog. 9, e1003211 (2013).
Namazi, G. et al. J. Infect. Dis. 218, 1954–1963 (2018).
Streeck, H. et al. J. Virol. 83, 7641–7648 (2009).
Borducchi, E. N. et al. Nature 540, 284–287 (2016).
Nishimura, Y. et al. Nature 543, 559–563 (2017).
Muccini, C. et al. AIDS Res. Ther. 16, 25 (2019).
Julg, B. et al. Lancet HIV 6, e259–e268 (2019).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Mothe, B., Brander, C. Small steps forward for HIV vaccine development. Nat Med 26, 466–467 (2020). https://doi.org/10.1038/s41591-020-0837-0
Published:
Issue date:
DOI: https://doi.org/10.1038/s41591-020-0837-0
